Kathryn Bizzak
Family · du Bois, PANPI 1326629742
Payments from drug & device makers
Across 326 payments — averaging $28.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$4K
- AbbVie$949
- Viiv Healthcare Company$739
- Organogenesis Inc.$416
- Amgen$381
- Paratek Pharmaceuticals, Inc.$359
- plus $2K from 33 others
What the payments were for
- Consulting fees$1,74519%
- Travel & lodging$1,55417%
- Food & beverage$5,85264%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 49 | $3,852 |
| AbbVie | 57 | $949 |
| Viiv Healthcare Company | 41 | $739 |
| Organogenesis Inc. | 15 | $416 |
| Amgen | 15 | $381 |
| Paratek Pharmaceuticals, Inc. | 21 | $359 |
| Novo Nordisk | 18 | $282 |
| Smith+Nephew | 9 | $234 |
| Pfizer | 11 | $198 |
| Insmed, Inc. | 11 | $192 |
| Merck | 8 | $141 |
| Indivior Inc. | 7 | $141 |
| Theratechnologies Inc. | 6 | $94 |
| Nestle Healthcare Nutrition Inc. | 6 | $91 |
| Urgo Medical North America, LLC | 3 | $83 |
| Lilly USA, LLC | 4 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $69 |
| Sumitomo Pharma America, Inc. | 3 | $64 |
| Exact Sciences | 3 | $64 |
| Astellas Pharma US Inc | 3 | $64 |
| Tactile Systems Technology Inc | 2 | $58 |
| Ferring Pharmaceuticals Inc. | 3 | $56 |
| Eisai Inc. | 3 | $55 |
| Stryker | 1 | $52 |
| Aimmune Therapeutics, Inc. | 3 | $51 |
| Grifols USA, LLC | 2 | $41 |
| GSK | 2 | $41 |
| Lundbeck LLC | 2 | $39 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Cumberland Pharmaceuticals, Inc. | 2 | $37 |
| AstraZeneca | 2 | $36 |
| Hologic Sales And Service, LLC | 1 | $31 |
| Ardelyx, Inc. | 1 | $23 |
| Mimedx Group, Inc. | 1 | $22 |
| Braeburn Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| CSL Behring | 1 | $19 |
| Bioventus LLC | 1 | $18 |
| Pharming Healthcare, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,151 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 19 | $74,070 |
| DescovyEmtricitabine/Tenofov Alafenam | 13 | $31,173 |
| OzempicSemaglutide | 20 | $18,249 |
| MounjaroTirzepatide | 14 | $13,019 |
| EliquisApixaban | 14 | $7,464 |
| Methenamine Hippurate | 61 | $4,619 |
| Entecavir | 14 | $796 |
| Doxycycline Hyclate | 29 | $540 |
| Cefdinir | 18 | $525 |
| Cefadroxil | 20 | $322 |
| Pregabalin | 27 | $263 |
| Lisinopril | 32 | $248 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $220 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 30 | $204 |
| Oxybutynin Chloride | 11 | $169 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy | $3,852 | $105,24232 claims |
| Novo NordiskOzempic | $282 | $18,24920 claims |
| Lilly USA, LLCMounjaro | $70 | $13,01914 claims |
| PfizerEliquis | $198 | $7,46414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,717 family providers in Pennsylvania.
Other family in du Bois
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.